
Synlait Milk Ltd (ASX: SM1) has lost its Chief Executive Officer Richard Wyeth in the midst of the company’s attempt to turn its fortunes around.
Directors and execs depart
It’s also the latest in a string of executive and director resignations in recent weeks, with independent director Paulk McGilvary resigning earlier this week.
Last month Chief Quality Officer Hila Mory resigned, and Chief Supply Chain and Technology Officer Robert Stowell also resigned in early April.
Turnaround story?
Synlait in March released a letter to its shareholders saying it had been “another period of challenge” for the company.
The company acknowledged that shareholders would find the company’s performance “frustratingly disappointing”.
The company added:
The result reflects a period where Synlait faced multiple headwinds with little choice as to how to deal with them. At every stage we carefully analysed, costed and weighed up our options. Even with the benefit of hindsight, there is little we could have done differently that would have improved this result. Suffice to say building optionality into the business is a critical focus for our recovery.
For the first half ending January 31, Synlait posted a net loss of NZ$80.6 million, compared with a net profit of NZ$4.8 million for the previous corresponding period, on revenue of NZ$777.5 million, down from NZ$779 million.
In a joint statement at the time of the results release Mr Wyeth said the company was focused on six main levers to turn the company around.
He has now resigned, however will remain with the company until 30 June “to support an orderly transition and handover”.
Current board director Leon Fung will take over as acting chief executive while a new leader for the company is found.
Recall flagged
Synlait said earlier this month it was assisting The a2 Milk Company Ltd (ASX: A2M) with its voluntary recall of batches of a2 Platinum USA infant milk formula due to the presence of cereulide.
Synlait said it had manufactured the product in compliance with relevant standards at the time.
The company added:
The recall was initiated after cereulide was detected through additional testing that was undertaken after new directives from New Zealand’s Ministry for Primary Industries. The product was discontinued prior to the recall.
Synlait also this month said it had received two waivers in relation to its syndicated banking facilities.
The company had asked for its financiers to waive the quarterly minimum EBITDA “event of review threshold” and waive its interest cover ratio for the April 30 test date.
Synlait Milk shares closed at 38.5 cents on Wednesday afternoon. The company is valued at $232.2 million.
The post Synlait Milk CEO resigns – the latest in a line of executive departures appeared first on The Motley Fool Australia.
Should you invest $1,000 in Synlait Milk right now?
Before you buy Synlait Milk shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Synlait Milk wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Warning! Experts name 3 ASX 200 shares to sell
- Sell alert! Why this expert is calling time on Metcash and A2 Milk shares
- Are A2 Milk shares a buy after the 10% selloff on Monday?
- Why are A2 Milk shares crashing 13% to fresh 52-week lows?
- Why A2 Milk, Accent, Endeavour, and Woodside shares are falling today
Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.